ABIOMED

Covidien, Boston Scientific Create Comparison Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians. Mission: ABIOMED’s entire team is dedicated to the principle that technology leadership and the spirit of innovation are essential to our business goals and to our mission. Our focus every day centers on four themes: • Saving Lives • Leading in Technology and Innovation • Growing Profitability and Shareholder Value • Creating a Winning Culture